Nov 10, 2026 · 7 min
Investors question AI infrastructure, telehealth and ad-tech growth
Coreweave Mixed, Hims & Hers Dips, Trade Desk Falls With Outlook Still in Question
The episode shows how earnings beats and ambitious growth stories can still falter when investors doubt demand, guidance, or long-term strategy.
- 1CoreWeave faces scrutiny over AI infrastructure demand, data-center development, community resistance, and its close relationship with Nvidia.
- 2Hims & Hers cut full-year EBITDA guidance for the third consecutive time as results weakened and its drug strategy shifted.
- 3Trade Desk beat quarterly expectations, but executive departures, AI adoption, and uncertainty around advertising technology kept pressure on shares.
Don't miss
Chinese EV makers’ renewed use of buttons and knobs shows how safety concerns and regulatory scrutiny are reshaping vehicle interfaces.
The brief
CoreWeave approaches earnings with questions extending beyond demand for AI infrastructure: data-center development, community resistance, the midterm elections, and its close relationship with Nvidia all matter.
Anne Guillén explains why Hims & Hers shares fell after another guidance cut, weaker quarterly results, and a shift from compounded GLP-1 drugs toward branded-drug partnerships.
The Trade Desk delivered an earnings beat, yet its stock remains sharply lower for the year as executive departures, AI adoption, and uncertainty around advertising technology cloud the outlook.
The episode’s broader technology signal comes from Chinese EV makers bringing back physical buttons and knobs, responding to safety concerns and regulatory scrutiny of digital controls.
Together, the movers show markets testing whether headline performance can support a durable growth case when strategy, execution, and public scrutiny remain unsettled.
Weekly email
State of the Pod, every Monday
The week's most-discussed names and stories from podcasts, with the moments behind them. Free, five minutes, unsubscribe in one click.